Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$16.55 - $18.64 $7,497 - $8,443
-453 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$16.71 - $19.9 $1,687 - $2,009
101 Added 28.69%
453 $8,000
Q4 2020

Jan 13, 2021

BUY
$15.39 - $18.97 $30 - $37
2 Added 0.57%
352 $6,000
Q3 2020

Nov 12, 2020

BUY
$17.1 - $19.19 $34 - $38
2 Added 0.57%
350 $6,000
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $948 - $1,267
-65 Reduced 15.74%
348 $6,000
Q1 2020

May 12, 2020

SELL
$13.02 - $20.31 $1,874 - $2,924
-144 Reduced 25.85%
413 $6,000
Q4 2019

Feb 07, 2020

BUY
$16.88 - $20.83 $2,464 - $3,041
146 Added 35.52%
557 $10,000
Q3 2019

Nov 14, 2019

BUY
$16.15 - $17.99 $6,637 - $7,393
411 New
411 $7,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.